RecruitingPhase 3NCT07499817
Effect of Pentoxyfilline on Endometrial Thickness and Frozen Embryo Transfer Outcomes
Sponsor
Beni-Suef University
Enrollment
100 participants
Start Date
Oct 1, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The aim of this work was to investigate the effect of different vasodilators as pentoxifylline in women with unexplained infertility using IVF
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 43 Years
Inclusion Criteria1
- as good quality day five frozen embryos.
Exclusion Criteria3
- history of endocrine diseases,
- history of any previous surgery that couldm compromise the integrity of endometrium,
- cardiovascular, renal and liver diseases,
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGpentoxifylline 400 mg
Once daily in form of (Trental ® Sanofi co.) daily in addition to the above treatment protocol from the first day of the cycle until the day of starting progesterone.
OTHER(control)
estradiol valerate 2 mg. in form of (Cycloprogynova® Bayer Shering Pharma) whitepills starting dose is one pill T.I.D
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07499817
Related Trials
Inherited Reproductive Disorders
NCT015004472 locations
Measuring Free Radicals in Human Sperm Cells Related to Microbiota and Lifestyle Factors
NCT055142231 location
Interest of Sperm Insemination at 42 Hours Post hCG Compared to 36h in Intrauterine Insemination
NCT068045384 locations
Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy
NCT054406171 location
Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation
NCT062121022 locations